Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 10/20 | 0.54 |
| ▸ | CTSB | P07858 | 6/20 | 0.54 |
| ▸ | CTSL | P07711 | 2/20 | 0.54 |
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | CTSK | P43235 | 2/20 | 0.40 |
| ▸ | CCKBR | P32239 | 1/20 | 0.40 |
| ▸ | PYGL | P06737 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.37 |
| ▸ | TACR3 | P29371 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7696672 | 0.95 | CAPN1 (0.56) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7696690 | 0.91 | CAPN1 (0.54) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7694185 | 0.90 | CAPN1 (0.56) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7689853 | 0.87 | CAPN1 (0.59) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7697828 | 0.87 | CAPN1 (0.59) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7693068 | 0.86 | CAPN1 (0.70) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7693291 | 0.85 | CAPN1 (0.52) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7693912 | 0.84 | CAPN1 (0.73) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7690836 | 0.84 | CAPN1 (0.48) | CAPN1CTSBCTSLCTSSCTSK | |
| SCHEMBL7693664 | 0.82 | CAPN1 (0.53) | CAPN1CTSBCTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436925-B1 | BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES | ABBOTT LABORATORIES | 2002-08-20 | — | — | US | disclosed |